Artiva Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (ARTV)

Q: What does CUSIP 04317A107 represent in this 13F holders report?

CUSIP 04317A107 is the security identifier for ARTV - Artiva Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held ARTV - Artiva Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share in Q3 2026?

9 institutional investors reported ARTV - Artiva Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share for Q3 2026. Use the holders table for investor-level position and value details.

CUSIP: 04317A107

Q3 2026 13F Holders as of 30 Sep 2026

Security type / class: Equity / Common Stock, par value $0.0001 per share
Total 13F shares: 154,265
Total 13F value: $1,098,224
Share change: +30,538
SEC-reported price per share: $7.12
Number of holders: 9
Value change: +$217,431
Number of buys: 6
Shares outstanding: 48,657,048

Security key

04317A107

Report period

Q3 2026

Institutions

Top holders

ARTV full security history Ownership snapshot Full 13F holder table Previous quarter: Q2 2026 Artiva Biotherapeutics, Inc. SEC filings Artiva Biotherapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 04317A107

Previous quarter: Q2 2026

Recent filing periods:

Q3 2026 Q2 2026 Q1 2026 Q4 2025 Q3 2025

Ownership snapshot

Top reported holders of ARTV - Artiva Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

RA CAPITAL MANAGEMENT, L.P.

Disclosed value leader

RA CAPITAL MANAGEMENT, L.P.

Comparable rows

7/15

Latest evidence

10 Sep 2026

3/4/5 13D/G 13F Lead comparable stake: 38% 8 rows are not safely comparable across share classes. 13D/G row: RA CAPITAL MANAGEMENT, L.P. Showing 1-6 of 15 holder rows.

Quick read

RA CAPITAL MANAGEMENT, L.P. leads the comparable SEC ownership view at 38%.

7 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.

Comparable ownership Top 5

RA CAPITAL MANAGEMENT, L.P. 38%

GC Corp. 12%

VIKING GLOBAL INVESTORS LP 5.4%

venBio Global Strategic Fund III,... 4.9%

5AM Ventures VI, L.P. 4.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
RA CAPITAL MANAGEMENT, L.P.	3/4/5 13D/G 13F Director, 10%+ Owner · Company 3/4/5 13D/G 13F	38% Reported 13D/G · 22 Jul 2026	$197,082,402 19,515,958 shares mixed-class rows	+$117,678,225	10 Sep 2026
GC Corp.	13D/G 3/4/5 10%+ Owner 13D/G 3/4/5	12% Reported 13D/G · 11 May 2026	$70,376,516 5,999,703 shares	$0	11 May 2026
VIKING GLOBAL INVESTORS LP	13D/G 13F Company 13D/G 13F	5.4% Reported 13D/G · 11 May 2026	$30,546,867 2,604,166 shares	$0	11 May 2026
venBio Global Strategic Fund III, L.P.	13D/G 3/4/5 10%+ Owner 13D/G 3/4/5	4.9% Reported 13D/G · 31 Mar 2025	$2,937,489 1,198,975 shares	$0	31 Mar 2025
5AM Ventures VI, L.P.	13D/G Andrew J. Schwab 13D/G	4.8% Reported 13D/G · 30 Jun 2026	$21,015,005 2,353,304 shares	$0	30 Jun 2026
Venrock Healthcare Capital Partners III, L.P.	13D/G 13D/G	4.2% Reported 13D/G · 30 Jun 2026	$18,249,312 2,043,596 shares	$0	30 Jun 2026

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

154,265

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q2 2026 Across Filers

Q2 2026 holders

Q3 2026 holders

Holder diff

-63

Investor	Q2 2026 Shares	Q3 2026 Shares	Share Diff	Share Chg %	Q2 2026 value	Q3 2026 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend